AnodyneWiki

Lormetazepam

Lormetazepam
Lormetazepam
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass335.20 g/mol [1]
Melting point206 °C [1]
Predicted LogP2.4 [1]
Structural Identifiers
[]
Molecular formulaC16H12Cl2N2O2
IUPAC name7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one
SMILESCN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl
InChIInChI=1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3
InChIKeyFJIKWRGCXUCUIG-UHFFFAOYSA-N
CAS number848-75-9
UNIIGU56C842ZA
PubChem CID13314
Pharmacokinetics[]
Elimination half-life10–12 hours
MetabolismHepatic
ExcretionRenal
Routes of administrationOral, intravenous[3]

Lormetazepam (also known as Methyllorazepam, N-Methyllorazepam, Loramet, Lormetazepamum, Chlorotemazepam, Wy-4082, (+-)-Lormetazepam, N05cd06, 212-700-5 or Noctamid) is a substance of the aniline and benzodiazepine class.

Chemistry

 []

Lormetazepam is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

Lormetazepam matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Lormetazepam, as a benzodiazepine, binds to the regulatory site between the α and γ subunits of γ-aminobutryic acid (GABA) A receptors with γ2 and α1, α2, α3, or α5 subunits. This facilitates the opening of the chloride channel allowing chloride ions to flow into the neuron resulting in hyperpolarization. Hyperpolarized neurons require greater simulation to reach their action potential threshold. The general inhibitory effect on neuronal depolarization produces the effects of lormetazepam. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target30
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28
shared target28

Medical side effects []

71 side effects listed on drug labels in (lormetazepam).

  • Aggression
  • Amnesia
  • Anger
  • Rage
  • Angioedema
  • Anxiety
  • Asthenia
  • Fatigue
  • Ataxia
  • Abnormal behaviour
  • Mental disorder
  • Confusional state
  • Feeling abnormal
  • Constipation
  • Libido decreased
  • Disturbance in sexual arousal
  • Delusion
  • Depersonalisation
  • Depression
  • Diplopia
  • Dizziness
  • Dysgeusia
  • Epilepsy
  • Dermatitis
  • Rash
  • Gastrointestinal disorder
  • Hallucination
  • Headache
  • Cardiac disorder
  • Hyperhidrosis
  • Hypersensitivity
  • Immune system disorder
  • Irritability
  • Nausea
  • Nervous system disorder
  • Nightmare
  • Paraesthesia
  • Pruritus
  • Psychotic disorder
  • Hyperacusis
  • Speech disorder
  • Withdrawal syndrome
  • Completed suicide
  • Suicide attempt
  • Tachycardia
  • Micturition disorder
  • Urethral disorder
  • Urinary tract disorder
  • Urticaria
  • Vomiting
  • Dry mouth
  • Agitation
  • Drug withdrawal syndrome
  • Muscular weakness
  • Skin disorder
  • Myalgia
  • Musculoskeletal discomfort
  • Abdominal pain upper
  • Disturbance in attention
  • Emotional disorder
  • Tension
  • Derealisation
  • Anterograde amnesia
  • Drug dependence
  • Dependence
  • Acute psychosis
  • Altered state of consciousness
  • Depressed level of consciousness
  • Bradyphrenia
  • Somnolence
  • Visual impairment

Indications

  • Distress
  • Drug abuse
  • Insomnia
  • Organic brain syndrome
  • Sleep disorder

Subjective effects []

bonzi / Lormetazepam []
Routes:
  • Oral (1 - 2mg)

Experience reports

Erowid

There are currently 1 experience reports involving lormetazepam on : []

 []

  • Brazil: Lormetazepam is a B1.[4]
  • Canada: Lormetazepam is a Schedule IV.
  • Germany: Lormetazepam is Prescription only/Anlage III.
  • United States: Lormetazepam is a Schedule IV under the "Controlled Substances Act".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 13314, Lormetazepam. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/13314
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lormetazepam. UNII: GU56C842ZA. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GU56C842ZA
  3. Horowski R. Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures. Journal of Neural Transmission. August 2020; 127(8):1107–1115. PMID 32468272. https://doi.org/10.1007/s00702-020-02209-8
  4. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 18:00:34
drugspromissing (no DrugsPRO reagent data)2026-11-20 18:00:30
erowidok2026-11-20 18:00:36
gsrsok2026-11-20 18:00:30
hmdbmissing (hmdb.ca refused automated access to HMDB0041919)2026-11-20 18:00:30
keggok2026-11-20 18:00:32
pubchemok2026-11-20 18:00:28
redditmissing (no r/tripreports posts mention it)2026-11-20 18:00:30
siderok2026-11-20 18:00:30
structureok2026-11-20 18:00:30
wikipediaok2026-11-20 18:00:30